| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 38.5893 | 3 |
| GSM780708 | Untreated after 4 days (C2_1) | 40.2627 | 7 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.7546 | 16 |
| GSM780719 | Untreated after 4 days (C1_2) | 38.427 | 3 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.2614 | 42 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.425 | 19 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.411 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.794 | 12 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 40.6315 | 8 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.6607 | 8 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.8323 | 44 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.4982 | 15 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.4807 | 24 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 40.4684 | 8 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.606 | 16 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.1334 | 10 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.2165 | 28 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.9913 | 17 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 37.0049 | 1 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.9994 | 13 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.8951 | 22 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.3626 | 29 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.4411 | 34 |